CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Income Taxes Payable
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Income Taxes Payable of $0 for the 12-month period ending 2019-12-28, per its 10-K filed 2020-02-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2020-02-11
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in income taxes payable for fiscal 2019 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in income taxes payable for fiscal 2018 was -$8.97M, a 114.70% decline from fiscal 2017.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in income taxes payable for fiscal 2017 was $61.04M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in income taxes payable for fiscal 2016 was $0.00.
| Period end | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|
| 2019-12-28 | $0.00 10-K · filed 2020-02-11 |
| 2018-12-29 | -$8.97M 10-K · filed 2020-02-11 |
| 2017-12-30 | $61.04M 10-K · filed 2020-02-11 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-13 |
| 2015-12-26 | $0.00 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |